Ms. Carrie DiMarzio was appointed CEO of BioMedInnovations, LLC (“BMI”) in July 2020, having being COO since 2015, in recognition of her significant leadership role, not least in guiding BMI’s Federal national award-winning COVID response partnership with the Lawrence Livermore National Laboratory (LLNL), that resulted in achieving FDA EUA status for an emergency use ventilator, SuppleVent™. Ms. DiMarzio has also leads BMI’s work for the Cystic Fibrosis Foundation (CFF), undertaken with Duke University ExVivo Organ Lab, and the company’s deployment and partnerships in Yale University, UNC and Porter Adventist. Ms. DiMarzio has been involved with and managed every aspect of BMI’s corporate development since first joining the company. Current and prior experience includes being CEO of Industrial Hard Carbon, LLC (“IHC”), a precision engineering business that serves biomedical (in-vivo and ex-vivo prostheses and medical instruments) and other sectors, by providing microscopically thin and diamond-like hard surface film modifications. Ms. DiMarzio introduced Quality Assurance processes to BMI, achieving ISO 9000 and ISO 13485 certifications, and she is known for her attention to detail, for personal commitment to company, team and stakeholders alike, and her remarkable ability to elicit individual ‘personal bests’ from the high performing teams under her charge.